Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Short term Debt (2016 - 2025)

Historic Short term Debt for BioRestorative Therapies (BRTX) over the last 11 years, with Q3 2025 value amounting to $2.0 million.

  • BioRestorative Therapies' Short term Debt fell 4303.83% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 4303.83%. This contributed to the annual value of $2.5 million for FY2024, which is 371.22% down from last year.
  • Per BioRestorative Therapies' latest filing, its Short term Debt stood at $2.0 million for Q3 2025, which was down 4303.83% from $2.6 million recorded in Q2 2025.
  • BioRestorative Therapies' Short term Debt's 5-year high stood at $14.2 million during Q1 2022, with a 5-year trough of $14687.0 in Q1 2021.
  • Over the past 5 years, BioRestorative Therapies' median Short term Debt value was $2.8 million (recorded in 2024), while the average stood at $4.0 million.
  • Its Short term Debt has fluctuated over the past 5 years, first crashed by 9966.43% in 2021, then soared by 9662103.22% in 2022.
  • Over the past 5 years, BioRestorative Therapies' Short term Debt (Quarter) stood at $58970.0 in 2021, then skyrocketed by 9297.55% to $5.5 million in 2022, then tumbled by 52.76% to $2.6 million in 2023, then fell by 3.71% to $2.5 million in 2024, then dropped by 21.92% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.6 million for Q2 2025, and $3.2 million during Q1 2025.